Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - OTHER CURRENT ASSETS
Other Current Assets AVXL - Anavex Life Sciences Corp.
931 K
LAST VALUE
62.17%
2 YEAR CAGR
13.19%
5 YEAR CAGR
26.44%
10 YEAR CAGR